Literature DB >> 11793467

New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene.

William S Oetting1.   

Abstract

Albinism ocular type 1 (OA1) is an X-linked type of albinism that mainly effects pigment production in the eye, resulting in hypopigmentation of the retina, nystagmus, strabismus, foveal hypoplasia, abnormal crossing of the optic fibers, and reduced visual acuity. The OA1 gene is located on chromosome Xp22.32 and the coding sequence is divided into nine exons. The protein is an integral transmembrane protein that has weak similarities to G protein-coupled receptors. A total of 25 missense, two nonsense, nine frameshift, and five splicing mutations have been reported in the OA1 gene associated with OA1. There are also several deletions of some or all exons of the OA1 gene with deletions of exon 2 resulting from unequal crossing-over, due to flanking Alu repeats. Mutation and polymorphism data on this gene is available from the International Albinism Center - Albinism Database web site (http://www.cbc.umn.edu/tad). Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793467     DOI: 10.1002/humu.10034

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

1.  Accuracy of Next-Generation Sequencing for Molecular Diagnosis in Patients With Infantile Nystagmus Syndrome.

Authors:  John Hoon Rim; Seung-Tae Lee; Heon Yung Gee; Byung Joo Lee; Jong Rak Choi; Hye Won Park; Sueng-Han Han; Jinu Han
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

2.  Identification of a novel GPR143 mutation in X-linked ocular albinism with marked intrafamilial phenotypic variability.

Authors:  Jae-Ho Jung; Eun Hye Oh; Jin-Hong Shin; Hyang-Sook Kim; Seo Young Choi; Kwang-Dong Choi; Changwook Lee; Jae-Hwan Choi
Journal:  J Genet       Date:  2018-12       Impact factor: 1.166

Review 3.  Pigmentation and vision: Is GPR143 in control?

Authors:  Brian S McKay
Journal:  J Neurosci Res       Date:  2018-05-14       Impact factor: 4.164

4.  Deep intronic GPR143 mutation in a Japanese family with ocular albinism.

Authors:  Takuya Naruto; Nobuhiko Okamoto; Kiyoshi Masuda; Takao Endo; Yoshikazu Hatsukawa; Tomohiro Kohmoto; Issei Imoto
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

5.  Molecular genetic and clinical evaluation of three Chinese families with X-linked ocular albinism.

Authors:  Xuan Zou; Hui Li; Lizhu Yang; Zixi Sun; Zhisheng Yuan; Huajin Li; Ruifang Sui
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

6.  A novel nonsense mutation of the GPR143 gene identified in a Chinese pedigree with ocular albinism.

Authors:  Naihong Yan; Xuan Liao; Su-ping Cai; Changjun Lan; Yun Wang; Xiaomin Zhou; Yan Yin; Wenhan Yu; Xuyang Liu
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

7.  A novel GPR143 duplication mutation in a Chinese family with X-linked congenital nystagmus.

Authors:  Yuanyuan Peng; Yan Meng; Zheng Wang; Mei Qin; Xiaoqiao Li; Yan Dian; Shangzhi Huang
Journal:  Mol Vis       Date:  2009-04-22       Impact factor: 2.367

8.  Identification of three novel OA1 gene mutations identified in three families misdiagnosed with congenital nystagmus and carrier status determination by real-time quantitative PCR assay.

Authors:  Valérie Faugère; Sylvie Tuffery-Giraud; Christian Hamel; Mireille Claustres
Journal:  BMC Genet       Date:  2003-01-07       Impact factor: 2.797

9.  Identification of a novel GPR143 deletion in a Chinese family with X-linked congenital nystagmus.

Authors:  Pingtong Zhou; Zhiqiang Wang; Jing Zhang; Landian Hu; Xiangyin Kong
Journal:  Mol Vis       Date:  2008-05-30       Impact factor: 2.367

10.  Simultaneous Expression of ABCA4 and GPR143 Mutations: A Complex Phenotypic Manifestation.

Authors:  Winston Lee; Kaspar Schuerch; Yajing Xie; Jana Zernant; Stephen H Tsang; Janet R Sparrow; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.